Latest filing published 26 Mar 2024 for LSL Pharma Group Inc., €1.3M.
No signal scores available.
Jacques Grimard appears in our data through filings on LSL Pharma Group Inc. shares, published by SEDI. In total, 3 filings cover trades dated 18 March 2024.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 26 March 2024, the filings show a transaction worth €1.3M in LSL Pharma Group Inc. Between a trade and the moment it shows up on SEDI, the median delay is 7 days. This delay matters because a trade only becomes useful information once it is public. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations